www.curatherapeutics.com
Innovation Type:
Therapeutics
Cancer Type:
Pancreas
Funding Stage:
pre-seed
Fund:
Prospects
Developing a best-in-class multimodal immunotherapy with potent anti-metastatic properties to treat pancreatic cancer.

Related news

FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program

The Women’s Synergistic Entrepreneurship and Economic Development (WeSEED) program leverages the combined, complementary capital, expertise and resources of OBIO® and FACIT. The resulting synergies provide a continuum of seamless support and lower barriers faced by women STEM leaders in accessing business training, advisory resources, networks and venture funding. Read More

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.